Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: CRISPR-Cas12a combination to alleviate the false-positive in loop-mediated isothermal amplification-based diagnosis of Neisseria meningitidis

Fig. 1

Addition of CRISPR-Cas12a help to alleviate false positive acquired by single use of LAMP performance: (upper left panel) the product mixture of LAMP assay was colometric indicated by addition of 100 uM Hydroxy naphthol blue (HNB Sigma—Singapore) or (downer left panel) resolved against 1.2% agarose gel electrophoresis. Right panel—the same product mixture of LAMP was treated with CRISPR-Cas12a

Back to article page